1 Market Overview of Osteoporosis Therapeutics 1.1 Osteoporosis Therapeutics Market Overview 1.1.1 Osteoporosis Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Osteoporosis Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Osteoporosis Therapeutics Market Size by Region (2015-2026) 1.4 Global Osteoporosis Therapeutics Historic Market Size by Region (2015-2020) 1.5 Global Osteoporosis Therapeutics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 1.6.1 North America Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 1.6.2 Europe Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) 2 Osteoporosis Therapeutics Market Overview by Type 2.1 Global Osteoporosis Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Osteoporosis Therapeutics Historic Market Size by Type (2015-2020) 2.3 Global Osteoporosis Therapeutics Forecasted Market Size by Type (2021-2026) 2.4 Bisphosphonates 2.5 Hormones 2.6 Strontium Ranelate 2.7 Raloxifene 2.8 Denosumab 2.9 Others 3 Osteoporosis Therapeutics Market Overview by Application 3.1 Global Osteoporosis Therapeutics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Osteoporosis Therapeutics Historic Market Size by Application (2015-2020) 3.3 Global Osteoporosis Therapeutics Forecasted Market Size by Application (2021-2026) 3.4 Hospital Pharmacies 3.5 Online Pharmacies 3.6 Retail Pharmacies 4 Global Osteoporosis Therapeutics Competition Analysis by Players 4.1 Global Osteoporosis Therapeutics Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2019) 4.3 Date of Key Manufacturers Enter into Osteoporosis Therapeutics Market 4.4 Global Top Players Osteoporosis Therapeutics Headquarters and Area Served 4.5 Key Players Osteoporosis Therapeutics Product Solution and Service 4.6 Competitive Status 4.6.1 Osteoporosis Therapeutics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Warner Chilcott 5.1.1 Warner Chilcott Profile 5.1.2 Warner Chilcott Main Business 5.1.3 Warner Chilcott Products, Services and Solutions 5.1.4 Warner Chilcott Revenue (US$ Million) & (2015-2020) 5.1.5 Warner Chilcott Recent Developments 5.2 Merck & Co. 5.2.1 Merck & Co. Profile 5.2.2 Merck & Co. Main Business and Company’s Total Revenue 5.2.3 Merck & Co. Products, Services and Solutions 5.2.4 Merck & Co. Revenue (US$ Million) (2015-2020) 5.2.5 Merck & Co. Recent Development and Reaction to Covid-19 5.3 Roche 5.5.1 Roche Profile 5.3.2 Roche Main Business 5.3.3 Roche Products, Services and Solutions 5.3.4 Roche Revenue (US$ Million) & (2015-2020) 5.3.5 Novartis Recent Developments 5.4 Novartis 5.4.1 Novartis Profile 5.4.2 Novartis Main Business 5.4.3 Novartis Products, Services and Solutions 5.4.4 Novartis Revenue (US$ Million) & (2015-2020) 5.4.5 Novartis Recent Developments 5.5 Ono 5.5.1 Ono Profile 5.5.2 Ono Main Business 5.5.3 Ono Products, Services and Solutions 5.5.4 Ono Revenue (US$ Million) & (2015-2020) 5.5.5 Ono Recent Developments 5.6 Astellas Pharma 5.6.1 Astellas Pharma Profile 5.6.2 Astellas Pharma Main Business 5.6.3 Astellas Pharma Products, Services and Solutions 5.6.4 Astellas Pharma Revenue (US$ Million) & (2015-2020) 5.6.5 Astellas Pharma Recent Developments 5.7 Procter & Gamble 5.7.1 Procter & Gamble Profile 5.7.2 Procter & Gamble Main Business and Company’s Total Revenue 5.7.3 Procter & Gamble Products, Services and Solutions 5.7.4 Procter & Gamble Revenue (US$ Million) (2015-2020) 5.7.5 Procter & Gamble Recent Development and Reaction to Covid-19 5.8 Sumitomo Pharmaceuticals 5.8.1 Sumitomo Pharmaceuticals Profile 5.8.2 Sumitomo Pharmaceuticals Main Business 5.8.3 Sumitomo Pharmaceuticals Products, Services and Solutions 5.8.4 Sumitomo Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.8.5 Sumitomo Pharmaceuticals Recent Developments 5.9 Servier 5.9.1 Servier Profile 5.9.2 Servier Main Business 5.9.3 Servier Products, Services and Solutions 5.9.4 Servier Revenue (US$ Million) & (2015-2020) 5.9.5 Servier Recent Developments 5.10 Eli Lilly 5.10.1 Eli Lilly Profile 5.10.2 Eli Lilly Main Business 5.10.3 Eli Lilly Products, Services and Solutions 5.10.4 Eli Lilly Revenue (US$ Million) & (2015-2020) 5.10.5 Eli Lilly Recent Developments 5.11 Pfizer 5.11.1 Pfizer Profile 5.11.2 Pfizer Main Business 5.11.3 Pfizer Products, Services and Solutions 5.11.4 Pfizer Revenue (US$ Million) & (2015-2020) 5.11.5 Pfizer Recent Developments 5.12 Amgen 5.12.1 Amgen Profile 5.12.2 Amgen Main Business 5.12.3 Amgen Products, Services and Solutions 5.12.4 Amgen Revenue (US$ Million) & (2015-2020) 5.12.5 Amgen Recent Developments 5.13 Chugai 5.13.1 Chugai Profile 5.13.2 Chugai Main Business 5.13.3 Chugai Products, Services and Solutions 5.13.4 Chugai Revenue (US$ Million) & (2015-2020) 5.13.5 Chugai Recent Developments 6 North America 6.1 North America Osteoporosis Therapeutics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Osteoporosis Therapeutics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Osteoporosis Therapeutics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Osteoporosis Therapeutics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Osteoporosis Therapeutics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Osteoporosis Therapeutics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Osteoporosis Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Osteoporosis Therapeutics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Osteoporosis Therapeutics Market Size Share by Region (2015-2020) Table 4. Global Osteoporosis Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Osteoporosis Therapeutics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Osteoporosis Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Osteoporosis Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Osteoporosis Therapeutics Revenue Market Share by Type (2015-2020) Table 9. Global Osteoporosis Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Osteoporosis Therapeutics Revenue Market Share by Type (2021-2026) Table 11. Global Osteoporosis Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Osteoporosis Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Osteoporosis Therapeutics Revenue Market Share by Application (2015-2020) Table 14. Global Osteoporosis Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Osteoporosis Therapeutics Revenue Market Share by Application (2021-2026) Table 16. Global Osteoporosis Therapeutics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Osteoporosis Therapeutics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2019) Table 19. Date of Key Manufacturers Enter into Osteoporosis Therapeutics Market Table 20. Global Osteoporosis Therapeutics Top Players Headquarters and Area Served Table 21. Osteoporosis Therapeutics Product Solution and Service Table 22. Global Osteoporosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Warner Chilcott Basic Information List Table 25. Warner Chilcott Description and Business Overview Table 26. Warner Chilcott Osteoporosis Therapeutics Products, Services and Solutions Table 27. Revenue (Million US$) in Osteoporosis Therapeutics Business of Warner Chilcott (2015-2020) Table 28. Warner Chilcott Recent Developments Table 29. Merck & Co. Basic Information List Table 30. Merck & Co. Description and Business Overview Table 31. Merck & Co. Osteoporosis Therapeutics Products, Services and Solutions Table 32. Revenue (Million US$) in Osteoporosis Therapeutics Business of Merck & Co. (2015-2020) Table 33. Merck & Co. Recent Developments Table 34. Roche Basic Information List Table 35. Roche Description and Business Overview Table 36. Roche Osteoporosis Therapeutics Products, Services and Solutions Table 37. Revenue (Million US$) in Osteoporosis Therapeutics Business of Roche (2015-2020) Table 38. Roche Recent Developments Table 39. Novartis Basic Information List Table 40. Novartis Description and Business Overview Table 41. Novartis Osteoporosis Therapeutics Products, Services and Solutions Table 42. Revenue (Million US$) in Osteoporosis Therapeutics Business of Novartis (2015-2020) Table 43. Novartis Recent Developments Table 44. Ono Basic Information List Table 45. Ono Description and Business Overview Table 46. Ono Osteoporosis Therapeutics Products, Services and Solutions Table 47. Revenue (Million US$) in Osteoporosis Therapeutics Business of Ono (2015-2020) Table 48. Ono Recent Developments Table 49. Astellas Pharma Basic Information List Table 50. Astellas Pharma Description and Business Overview Table 51. Astellas Pharma Osteoporosis Therapeutics Products, Services and Solutions Table 52. Revenue (Million US$) in Osteoporosis Therapeutics Business of Astellas Pharma (2015-2020) Table 53. Astellas Pharma Recent Developments Table 54. Procter & Gamble Basic Information List Table 55. Procter & Gamble Description and Business Overview Table 56. Procter & Gamble Osteoporosis Therapeutics Products, Services and Solutions Table 57. Revenue (Million US$) in Osteoporosis Therapeutics Business of Procter & Gamble (2015-2020) Table 58. Procter & Gamble Recent Developments Table 59. Sumitomo Pharmaceuticals Basic Information List Table 60. Sumitomo Pharmaceuticals Description and Business Overview Table 61. Sumitomo Pharmaceuticals Osteoporosis Therapeutics Products, Services and Solutions Table 62. Revenue (Million US$) in Osteoporosis Therapeutics Business of Sumitomo Pharmaceuticals (2015-2020) Table 63. Sumitomo Pharmaceuticals Recent Developments Table 64. Servier Basic Information List Table 65. Servier Description and Business Overview Table 66. Servier Osteoporosis Therapeutics Products, Services and Solutions Table 67. Revenue (Million US$) in Osteoporosis Therapeutics Business of Servier (2015-2020) Table 68. Servier Recent Developments Table 69. Eli Lilly Basic Information List Table 70. Eli Lilly Description and Business Overview Table 71. Eli Lilly Osteoporosis Therapeutics Products, Services and Solutions Table 72. Revenue (Million US$) in Osteoporosis Therapeutics Business of Eli Lilly (2015-2020) Table 73. Eli Lilly Recent Developments Table 74. Pfizer Basic Information List Table 75. Pfizer Description and Business Overview Table 76. Pfizer Osteoporosis Therapeutics Products, Services and Solutions Table 77. Revenue (Million US$) in Osteoporosis Therapeutics Business of Pfizer (2015-2020) Table 78. Pfizer Recent Developments Table 79. Amgen Basic Information List Table 80. Amgen Description and Business Overview Table 81. Amgen Osteoporosis Therapeutics Products, Services and Solutions Table 82. Revenue (Million US$) in Osteoporosis Therapeutics Business of Amgen (2015-2020) Table 83. Amgen Recent Developments Table 84. Chugai Basic Information List Table 85. Chugai Description and Business Overview Table 86. Chugai Osteoporosis Therapeutics Products, Services and Solutions Table 87. Revenue (Million US$) in Osteoporosis Therapeutics Business of Chugai (2015-2020) Table 88. Chugai Recent Developments Table 89. North America Osteoporosis Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 90. North America Osteoporosis Therapeutics Market Size Share by Country (2015-2020) Table 91. Europe Osteoporosis Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 92. Europe Osteoporosis Therapeutics Market Size Share by Country (2015-2020) Table 93. Asia-Pacific Osteoporosis Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 94. Asia-Pacific Osteoporosis Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 95. Latin America Osteoporosis Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 96. Latin America Osteoporosis Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 97. Middle East & Africa Osteoporosis Therapeutics Market Size by Players (2015-2020) (US$ Million) Table 98. Middle East & Africa Osteoporosis Therapeutics Market Size Share by Players (2015-2020) (US$ Million) Table 99. Osteoporosis Therapeutics Market Trends Table 100. Osteoporosis Therapeutics Market Drivers Table 101. Osteoporosis Therapeutics Market Challenges Table 102. Osteoporosis Therapeutics Market Restriants Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Osteoporosis Therapeutics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Osteoporosis Therapeutics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Osteoporosis Therapeutics Market Share by Regions: 2020 VS 2026 Figure 4. North America Osteoporosis Therapeutics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Osteoporosis Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Osteoporosis Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Osteoporosis Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Osteoporosis Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Osteoporosis Therapeutics Market Share by Type in 2020 & 2026 Figure 10. Bisphosphonates Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Hormones Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Strontium Ranelate Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Raloxifene Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Denosumab Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Global Osteoporosis Therapeutics Market Size Share by Application in 2020 & 2026 Figure 17. Hospital Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Online Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 19. Retail Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 20. Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Top 5 and Top 10 Players Osteoporosis Therapeutics Market Share in 2019 Figure 22. United States Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Canada Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Germany Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. France Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. U.K. Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Italy Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Russia Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Nordic Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Rest of Europe Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. China Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Japan Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. South Korea Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Southeast Asia Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. India Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Australia Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Asia-Pacific Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Mexico Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Brazil Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Latin America Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Turkey Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Saudi Arabia Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. UAE Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Rest of Middle East & Africa Osteoporosis Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation

Warner Chilcott Merck & Co. Roche Novartis Ono Astellas Pharma Procter & Gamble Sumitomo Pharmaceuticals Servier Eli Lilly Pfizer Amgen Chugai